Sat, 15 Aug 2026
04:07:59 pm
Rudransh Sangwan
Published at: August 8, 2026, 7:29 AM
Synopsis
Consint.AI raises ₹22 crore in Series A funding from Equanimity Ventures and Seafund to expand its AI-powered healthcare technology solutions, including claims automation, fraud detection, hospital analytics and patient record management. The funding highlights growing investor interest in Indian HealthTech, AI startups, healthcare automation and digital health innovation.

India’s healthtech and artificial intelligence startup ecosystem is seeing growing interest in technologies that can improve healthcare efficiency, automate complex processes and reduce operational costs. Against this backdrop, Consint.AI has raised ₹22 crore ($2.30 million) in Series A funding, marking its latest funding round as the Noida-based startup looks to strengthen its technology and expand its presence across healthcare insurance, claims management and hospital operations.
The latest funding round was announced on August 7, 2026, with Equanimity Ventures and Seafund participating as investors. The company is developing AI-powered solutions aimed at addressing some of the biggest challenges in healthcare administration, including claims processing, fraud detection, patient record management and hospital analytics. The Series A round follows an earlier ₹5 crore ($0.58 million) seed funding round raised in January 2025, also backed by Equanimity Ventures and Seafund.
The ₹22 crore Series A funding round represents a significant increase over Consint.AI's previous funding and provides the startup with additional capital to develop its artificial intelligence capabilities and expand its healthcare technology platform. The round was backed by Equanimity Ventures and Seafund, both of which had previously invested in the company during its seed stage.
The latest investment comes as healthcare providers and insurance companies increasingly look toward AI driven automation to handle large volumes of medical information, insurance documents and claims. Consint.AI is positioning its technology around these areas, with its platform designed to help organizations automate processes while improving the accuracy and efficiency of healthcare operations.
| Particulars | Details |
|---|---|
| Company | Consint.AI |
| Legal Entity | Consint Solutions Private Limited |
| Latest Funding | ₹22 crore |
| Funding Round | Series A |
| Funding Date | August 7, 2026 |
| Investors | Equanimity Ventures, Seafund |
| Previous Funding | ₹5 crore |
| Previous Round | Seed |
| Previous Funding Date | January 6, 2025 |
| Location | Noida, India |
| Sector | AI, HealthTech |
One of the central areas of Consint.AI's business is the use of artificial intelligence in healthcare insurance and claims processing. Insurance claims can involve large amounts of documentation, medical records and supporting information, creating significant administrative workloads for insurers and hospitals.
Consint.AI's technology is designed to use Generative AI and large language models (LLMs) to process and interpret healthcare information. The company aims to help organizations identify relevant information from documents, automate claims-related workflows and improve decision-making across healthcare transactions.
The startup's solutions also focus on AI-powered fraud analytics, allowing insurers and healthcare organizations to identify unusual patterns and potential anomalies. By automating parts of the fraud detection and claims assessment process, the technology is intended to help organizations reduce costs while improving operational efficiency.
Consint.AI has developed a portfolio of AI-powered products targeting different parts of the healthcare ecosystem.
| Solution | Primary Focus |
|---|---|
| Risk.ai | AI-powered fraud detection and anomaly tracking |
| AutoClaim.ai | Automated healthcare claims processing |
| CIPHR.ai | AI-powered patient record management |
Risk.ai focuses on identifying potential fraud and unusual activity across healthcare transactions. The system is designed to help organizations detect anomalies that may require further investigation, potentially strengthening fraud prevention and risk management processes.
AutoClaim.ai is focused on claims automation, helping reduce the manual work involved in processing healthcare insurance claims. Meanwhile, CIPHR.ai focuses on patient record management by using AI to organize and manage healthcare information, creating opportunities for hospitals and other healthcare organizations to improve access to patient data.
A major part of Consint.AI's technology proposition is its use of Generative AI and large language models. Healthcare organizations handle substantial amounts of unstructured information, including medical documents, insurance records and other patient-related data, making document intelligence an important area for automation.
The company's platform is designed to provide document insights, compliance-ready hospital analytics and patient verification capabilities. It also incorporates facial recognition technology for patient verification, according to the company's profile, adding another layer of technology to its healthcare operations platform.
Consint.AI's technology is described as ABDM-ready, aligning its solutions with India's Ayushman Bharat Digital Mission and the country's broader push toward digital healthcare infrastructure. Integration with existing Hospital Information Systems (HIS) is also part of the company's technology proposition.
This focus could allow the startup to target healthcare organizations that are increasingly digitizing patient information and operational processes. By connecting AI-based tools with existing hospital systems, Consint.AI aims to make its technology applicable across insurance, hospitals and other healthcare-related operations rather than limiting it to a single use case.
The latest funding round was backed by Equanimity Ventures and Seafund, which have also participated in Consint.AI's earlier funding. The continued involvement of the investors provides the startup with backing as it moves from its earlier development phase into a larger Series A stage.
The funding also reflects the broader opportunity emerging at the intersection of artificial intelligence, healthcare technology and insurance automation. As healthcare organizations manage increasingly large amounts of data and documentation, AI-based solutions that can automate administrative processes and identify risks could become an important part of the sector's technology infrastructure.
Before its Series A round, Consint.AI raised ₹5 crore ($0.58 million) in seed funding in January 2025. The seed round was also backed by Equanimity Ventures and Seafund, giving the investors an existing relationship with the company before the latest capital infusion.
The progression from a ₹5 crore seed round to a ₹22 crore Series A round represents a substantial increase in the capital raised by the startup and provides additional resources for product development, technology infrastructure and business expansion.
Consint Solutions Private Limited, operating under the name Consint.AI, is a Noida-based HealthTech startup founded by Ashish Chaturvedi and Swadeep Singh. The company focuses on applying artificial intelligence to healthcare insurance, claims processing and hospital operations, with the broader objective of helping healthcare organizations automate workflows, identify risks and manage information more efficiently.
Its technology portfolio includes Risk.ai, AutoClaim.ai and CIPHR.ai, covering areas such as fraud analytics, automated claims processing and patient record management. The company combines AI, Generative AI, LLMs and automation with integrations for hospital systems, while its ABDM-ready approach aligns its technology with India's expanding digital healthcare ecosystem.
The ₹22 crore Series A investment gives Consint.AI additional financial backing as it seeks to expand its AI-powered healthcare technology offerings. The company's focus on claims automation, fraud detection, patient records and hospital analytics places it within several rapidly developing segments of the Indian HealthTech market.
For the broader startup ecosystem, the funding highlights increasing investor interest in AI startups solving sector-specific business problems, particularly where automation can reduce operational costs and improve efficiency. Consint.AI's latest round also adds to the growing pipeline of Indian AI and HealthTech startups raising institutional funding in 2026, with healthcare data, insurance technology and enterprise AI emerging as important areas of startup innovation.
Consint.AI has raised ₹22 crore ($2.30 million) in its Series A funding round, announced on August 7, 2026.
The Consint.AI Series A round was backed by Equanimity Ventures and Seafund. Both investors had also participated in the company's previous seed funding round.
Consint.AI is a Noida-based HealthTech startup that uses artificial intelligence to improve healthcare insurance, claims processing and hospital operations through solutions focused on fraud detection, automation and patient record management.
The company's main AI solutions include Risk.ai for fraud detection and anomaly tracking, AutoClaim.ai for automated claims processing, and CIPHR.ai for AI-powered patient record management.
Before its latest Series A round, Consint.AI raised ₹5 crore ($0.58 million) in seed funding in January 2025, with Equanimity Ventures and Seafund participating in that round as well.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Petronet LNG's Q1FY27 EBITDA rose 26% as Nomura retained its Rs 345 target and Buy rating, with volume recovery expected from 4QFY27.

Indian media and entertainment sector stock jumps 8% after SAT grants interim relief in a SEBI case, clearing a path for a ₹3,143 crore promoter...

Aerospace and defence business sees a sharp Q1 FY27 revenue jump as acquisitions, global partnerships and major defence orders reshape its growth...

Tarsons Products shares surge 12% to a 52-week high as trading volumes rise, despite weak Q1 profit.

Passenger vehicle stock falls nearly 6% after Q1 profit drops 78.54% to ₹859 crore. Revenue rises 9%, while JLR headwinds weigh on earnings and...